Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Centene Corporation
- Thermo Fisher Scientific
Comparative performance (base 100)
Each asset is worth 100 at October 17, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | Centene CorporationStock | Thermo Fisher ScientificStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | +96.7% | +27.4% |
| Annualized performanceAverage annual return that would produce the same total performance. | +97.2% | +27.5% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 47.3% | 29.3% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −32.7% | −31.5% |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 2.45 | 0.96 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.7% | −2.7% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 34.17B $ | 257.53B $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | Unavailable | 37.5 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 0.2 | 5.6 |
| Net marginShare of revenue retained as profit. | −2.8% | 15.0% |
| Return on equityReturn on equity (ROE). | −20.4% | 13.5% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +4.6% | +10.5% |
| Dividend yieldAnnual dividend relative to the share price. | None | 0.27% |
| Debt / equityFinancial debt relative to shareholders' equity. | 71% | 81% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- Centene Corporation / Thermo Fisher Scientific0.10
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.